Shelli Brunswick is CEO & Founder of SB Global LLC and an international keynote speaker on tech used for the betterment of humanity.
getty
At a recent forum hosted by the American Chamber of Commerce in Slovakia, focused on space medicine, one insight emerged: The next major advancement in healthcare may originate from orbit.
This is not a new thought. I explored it in an earlier article, where I examined how space-based research influences areas such as cardiovascular health, bone density and vision restoration. What has changed now is the urgency and scale of opportunity.
The conversation in Bratislava made it clear that the priority is no longer just discovery, but the rapid translation of space-based insights into improved health outcomes on Earth.
The value of space as a research environment begins with one fundamental difference: the absence of gravity.
On Earth, gravity influences every biological process. It shapes how cells organize, how fluids circulate and how the body maintains balance. These forces are so constant that they are often invisible to us. In space, however, those constraints are removed, allowing scientists to observe biological behavior in entirely new ways.
This perspective is central to understanding how space is reshaping research in areas such as neurodegenerative disease, aging and precision medicine—an approach to healthcare that tailors treatments to an individual’s genetic profile, environment and lifestyle.
In microgravity, cells behave differently, proteins form with greater precision and researchers can isolate variables that are difficult to control on Earth. As NASA research has shown, studying biological systems in space reveals mechanisms often masked by gravity, providing insights that are difficult to obtain in traditional laboratory settings.
The result is a level of clarity that changes how quickly and effectively scientists can develop and test new therapies. Protein crystallization, for example, becomes more uniform in space, enabling more targeted drug design and improving the accuracy of treatments developed.
Space is becoming an integral part of the broader innovation landscape by enabling the refinement and validation of discoveries under unique conditions that are unattainable on Earth.
The impact of space on healthcare is most visible in how technologies originally built for astronauts are now redefining healthcare delivery around the world.
Space missions require solving for some of the most constrained conditions imaginable. There are no hospitals nearby, resources are limited, and decisions often need to be made in real time. These constraints have driven the development of highly efficient, portable and data-driven approaches to monitoring and maintaining human health.
Many of these innovations, such as remote monitoring, wearable sensors, advanced imaging and telemedicine, trace their origins to space-related challenges and have become essential to modern health. The significance of this transition lies in the capabilities they unlock.
This means healthcare is no longer bound by facilities. Connectivity, data and intelligent systems now extend care beyond traditional settings, enabling real-time monitoring, remote diagnostics and more informed decisions through integrated data streams. This is particularly consequential in regions historically underserved due to geography or infrastructure. Space-enabled connectivity is closing the healthcare access gap.
In this sense, the influence of space is redefining where and how healthcare happens.
Despite the pace of discovery and the growing availability of technology, one challenge continues to surface across healthcare: moving breakthroughs into real-world impact. The barrier lies in navigating complex regulations and operational environments to translate innovation into tangible value.
Healthcare operates in a highly regulated, deeply interconnected environment. New technologies must align with clinical workflows, meet regulatory standards, integrate with existing infrastructure and show clear value within established reimbursement models. At the same time, research institutions, commercial enterprises and healthcare providers often operate with different priorities and timelines.
The result is friction—not because the solutions are insufficient, but because the systems required to support them are not fully aligned. This dynamic is well-recognized across healthcare. Research on translational science consistently shows that moving from discovery to clinical impact remains one of the most complex and time-intensive stages in innovation.
In this context, progress depends on coordinated action among government, industry, academia and healthcare leaders. Sustainable impact requires mutually reinforcing partnerships and strategic alignment. This is where many promising innovations slow, not at the point of discovery, but at the point of integration.
Space has always represented possibility. It has pushed us to imagine what lies beyond our current limits. Today, those possibilities are becoming outcomes that shape how we live, work and heal. Advances in orbit are becoming integrated into life on Earth and influencing how we study disease, develop treatments and deliver care in ways that are both practical and profound.
Space is redefining how healthcare is designed, delivered, and scaled. The future of medicine may be defined by how effectively we connect discovery to application, innovation to infrastructure and insight to measurable impact.
The next breakthrough could come from orbit. Its true value will be determined by how quickly—and how effectively—we bring it to Earth.
Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。